search
Back to results

EyeKon Medical Inc. Capsular Tension Ring Study (CTR)

Primary Purpose

Cataract Extraction

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Capsular Tension Ring
Sponsored by
EyeKon Medical, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cataract Extraction focused on measuring Cataract

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • The patient is in good general and ocular health, having a vision-reducing cataract in the intended operative eye.
  • The intended operative eye has a Snellen best corrected visual of 20/40 or worse for distance or the refraction worsens to this level with glare testing.
  • The patients' worse seeing Eye is 20/70 or better.
  • The patient is willing and able to complete all required postoperative visits.
  • The patient is willing to sign a statement of informed consent.
  • The patient is at least 21 years old.
  • The patient requires cataract surgery with IOL implantation.
  • The patient has observed or suspected weakened, torn, missing or otherwise compromised zonules (torn or missing estimated not to exceed one-third of the capsular bag diameter) due to Pseudoexfoliation Syndrome, Marfans Syndrome, trauma or other zonular compromising condition.
  • The capsule is intact during insertion.

Exclusion Criteria:

  • Only one functional eye
  • Capsular bag tearing beyond the point where the surgeon thinks it is in the best interest of the patient to have a capsular ring implanted
  • Significant zonular didlysis during surgery
  • Preoperative ocular infection
  • Ocular inflammation or uveitis
  • Amblyopia
  • Aniridia
  • Congenital cataracts
  • Cataracts due to rubella
  • Corneal disease
  • Diabetes
  • Preoperative intraocular pressure over 21 mm Hg
  • Iritis
  • Iris atrophy
  • Pseudophakic lens exchange
  • Microphthalmia
  • Optic atrophy
  • Macular degeneration
  • Retinal detachment
  • Retinal degeneration
  • Vitritis
  • Flat anterior chamber
  • Other conditions as noted by the surgeon which may compromise the safety of the patient or the accuracy of the study

Sites / Locations

  • Stephenson Eye Associates
  • Comprehensive Eye Care Ltd.
  • Brazosport Eye InstituteRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Device

Arm Description

Polymethylmethacrylate Capsular Tension Ring introduced into the posterior chamber of the eye following cataract surgery before the implantation of an intraocular lens.

Outcomes

Primary Outcome Measures

Visual Acuity
Best case visual acuity at 1 year of follow-up based upon LogMar score.

Secondary Outcome Measures

Adverse Events
Adverse events will be compared to the FDA historical grid and must be less than or equal to those shown in the grid on a percentage of patients enrolled basis.

Full Information

First Posted
January 5, 2015
Last Updated
March 10, 2023
Sponsor
EyeKon Medical, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT02332369
Brief Title
EyeKon Medical Inc. Capsular Tension Ring Study
Acronym
CTR
Official Title
EyeKon Medical, Inc. Capsular Tension Ring Clinical Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 2005 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
EyeKon Medical, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes

5. Study Description

Brief Summary
This study evaluates the safety and effectiveness of a capsular tension ring (CTR) when used during cataract surgery. Capsular Tension Rings are used during intraocular lens implantation to give added support in order to keep the intraocular lens well centered, especially in eyes with weak or partially absent zonules. In many cases, capsular tension rings allow a lens to be successfully implanted into an eye which otherwise could not have supported an intraocular lens.
Detailed Description
The clinical study of the CTR-10 and CTR-12 Capsular Tension Rings is to be conducted with the following objectives: Determine the ability of the device to maintain the shape of the capsular bag and therefore keep the intraocular lens centered; Determine post-operative visual acuity of patients receiving the capsular tension ring as a secondary method of determining the efficacy; Describe the occurrence and time course of postoperative complications and adverse reactions for capsular tension ring implant subjects; Describe the occurrence of postoperative complications for the implant group and their relationship to ocular complications. Identify groups within the implant study population that are at "high risk" of particular complications. Collect and analyze against those historical controls published by FDA data on: Overall Visual Acuity Best Case Visual Acuity Cumulative Hyphema Cumulative Macular Edema Cumulative Retinal Detachment Cumulative Pupillary Block Cumulative Lens Dislocation Cumulative Endophthalmitis Cumulative Hypopyon Cumulative Surgical Reintervention Persistent Macular Edema Persistent Corneal Edema Persistent Iritis Persistent Raised IOP Requiring treatment Frequency and degree of posterior capsule opacification The investigational plan for the clinical study of capsular tension rings is designed to satisfy the requirements of the Investigational Device Exemption (IDE) regulations, which require a well-controlled clinical trial with ongoing monitoring to evaluate the safety and efficacy of the intraocular lenses. The study will consist of adult patients who will be enrolled into the study. The results of these implants will be carefully monitored for approximately twelve (12) months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract Extraction
Keywords
Cataract

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
125 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Device
Arm Type
Experimental
Arm Description
Polymethylmethacrylate Capsular Tension Ring introduced into the posterior chamber of the eye following cataract surgery before the implantation of an intraocular lens.
Intervention Type
Device
Intervention Name(s)
Capsular Tension Ring
Primary Outcome Measure Information:
Title
Visual Acuity
Description
Best case visual acuity at 1 year of follow-up based upon LogMar score.
Time Frame
At all pre/post op CFR's for 1 year.
Secondary Outcome Measure Information:
Title
Adverse Events
Description
Adverse events will be compared to the FDA historical grid and must be less than or equal to those shown in the grid on a percentage of patients enrolled basis.
Time Frame
1 Year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The patient is in good general and ocular health, having a vision-reducing cataract in the intended operative eye. The intended operative eye has a Snellen best corrected visual of 20/40 or worse for distance or the refraction worsens to this level with glare testing. The patients' worse seeing Eye is 20/70 or better. The patient is willing and able to complete all required postoperative visits. The patient is willing to sign a statement of informed consent. The patient is at least 21 years old. The patient requires cataract surgery with IOL implantation. The patient has observed or suspected weakened, torn, missing or otherwise compromised zonules (torn or missing estimated not to exceed one-third of the capsular bag diameter) due to Pseudoexfoliation Syndrome, Marfans Syndrome, trauma or other zonular compromising condition. The capsule is intact during insertion. Exclusion Criteria: Only one functional eye Capsular bag tearing beyond the point where the surgeon thinks it is in the best interest of the patient to have a capsular ring implanted Significant zonular didlysis during surgery Preoperative ocular infection Ocular inflammation or uveitis Amblyopia Aniridia Congenital cataracts Cataracts due to rubella Corneal disease Diabetes Preoperative intraocular pressure over 21 mm Hg Iritis Iris atrophy Pseudophakic lens exchange Microphthalmia Optic atrophy Macular degeneration Retinal detachment Retinal degeneration Vitritis Flat anterior chamber Other conditions as noted by the surgeon which may compromise the safety of the patient or the accuracy of the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Barry L Bowyer, MSPH
Phone
7277930170
Email
barry@eyekonmedical.com
First Name & Middle Initial & Last Name or Official Title & Degree
Mark Robinson
Phone
7277930170
Email
Mark@eyekonmedical.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mark Robinson
Organizational Affiliation
Sponsor/CEO
Official's Role
Study Director
Facility Information:
Facility Name
Stephenson Eye Associates
City
Venice
State/Province
Florida
ZIP/Postal Code
34285
Country
United States
Individual Site Status
Completed
Facility Name
Comprehensive Eye Care Ltd.
City
Washington
State/Province
Missouri
ZIP/Postal Code
63090
Country
United States
Individual Site Status
Completed
Facility Name
Brazosport Eye Institute
City
Lake Jackson
State/Province
Texas
ZIP/Postal Code
77566
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christian Penland
Email
ljm.christianp@gmail.com
First Name & Middle Initial & Last Name & Degree
Jonathan Grady, MD

12. IPD Sharing Statement

Learn more about this trial

EyeKon Medical Inc. Capsular Tension Ring Study

We'll reach out to this number within 24 hrs